New research shows that each of us may have more control over the likelihood of getting Alzheimer’s than we thought.
Unbeknownst to Graham, the study would be benefiting much more than her heart. The Systolic Blood Pressure Intervention Trial (dubbed SPRINT MIND) was designed to see if dramatically lowering blood pressure could influence the risk of cognitive decline, including symptoms associated with Alzheimer’s disease.
The results are in, and provide evidence that lowering blood pressure has the benefit of also reducing risk for mild cognitive impairment (MCI), brain decline that may precede dementia, and probable dementia. Graham and others who participated in the study were taken aback by the results.
“It never occurred to me that controlling my blood pressure could protect me from dementia,” says Arthur Lane, 89, another participant in the study. “I think this is wonderful.”
Drug Treatments Prove Ineffective
Until now, researchers had little to offer when it came to positive steps to take to fend off cognitive decline. It was known that genes play a role in who gets dementia, and that age was a factor, but neither of those are under anyone’s control.
Accordingly, research has centered on drug treatments to battle the disease. But every anticipated breakthrough thus far has failed. With billions of potential dollars at stake, major drug companies have spent heavily on research, to no avail.
“The data are pretty soft on a lot of things,” says Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center, “so that was discouraging for the field and discouraging for the general public.”
Top Ways to Lower Blood Pressure Without DrugsAlthough study participants were able to make use of medications, there’s plenty you can do to keep your blood pressure in a safe range without resorting to drugs. From the Mayo Clinic, here are 10 ways to maintain a healthy blood pressure:
|
SPRINT MIND Results
“It’s one of the first real demonstrations of a lifestyle modification having an impact on late-life cognition,” says Petersen, who was not involved in the study.
The aim of the trial was to lower systolic blood pressure to a target of 120 mm Hg or lower over 3.2 years among a group of people with cardiovascular risk factors. High blood pressure is generally defined as a systolic pressure of 130 or greater. Pressure of 120 to 130 is considered elevated, while normal pressure is 120 or less.
Lowering blood pressure alone reduced the risk of mild cognitive impairment by 19 percent and probable all-cause dementia by 17 percent in study participants who achieved 120 mm Hg or less. No amyloid-targeting investigational drug has ever approached this magnitude of benefit. However, Dr. Sanjay Kaul at Cedars Sinai cautions that it’s not as impressive as it sounds. Kaul calculates that the absolute risk reduction was only 1.34 percent for MCI.
The results do “not represent a robust effect,” says Kaul. “However, this has to be interpreted in the context of lack of treatment effect on this outcome with currently available interventions and the relatively short duration of treatment exposure. So, promising data, but not the whole enchilada, as spun by trial investigators.”
The good news gets better. The class of drugs used to lower blood pressure had no effect. Cheap generics performed just as well as name brands. Men and women were equally benefited, and race had no impact. Finally, lowering systolic pressure in those older than 75 provided just as much benefit as it did for younger test subjects.
The rigorous, randomized study involved a sizeable group, including 9,300 elderly adults with heart problems or at risk of developing heart disease. Participants were randomly told to lower their systolic pressure to either less than 120 mm Hg or less than 140 mm Hg. The group was tested over an average of three years on different cognitive abilities, including memory and processing new information.
Lead study author Dr. Jeff Williamson reports that biologically, it doesn’t seem like blood pressure would affect dementia. He makes a comparison between air pressure in your tires, and blood pressure: neither should be too high or too low. “Over time, high blood pressure can damage the walls of very fragile arteries that deliver blood to the brain and other organs,” he says. “And that can produce some of the things we see associated with dementia: inflammation and small strokes.”
Time will Tell
Still, it’s the first time a large study has shown we may each have some control over whether or not we get dementia. “This provides great encouragement for people to say, yes, make sure your blood pressure is well controlled, because right now, it’s one of the things you can do,” says Williamson. “This opens the door to testing more interventions.”
Click below for the other articles in the November 2018 Senior Spirit
Sources:
http://time.com/5362176/alzheimers-prevention/
https://www.nhlbi.nih.gov/science/systolic-blood-pressure-intervention-trial-sprint-study
https://www.mdedge.com/clinicalneurologynews/article/171130/alzheimers-cognition/mild-cognitive-impairment-risk-slashed-19
https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/high-blood-pressure/art-20046974
http://www.cardiobrief.org/2018/07/26/no-a-big-nih-trial-did-not-show-that-lowering-blood-pressure-will-prevent-dementia/
Blog posting provided by Society of Certified Senior Advisors
www.csa.us